# A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.

> **NCT07176728** · PHASE1 · RECRUITING · sponsor: **Bayer** · enrollment: 16 (estimated)

## Conditions studied

- Sepsis Associated Disseminated Intravascular Coagulation (DIC)

## Interventions

- **DRUG:** BAY 3389934
- **DRUG:** Matching Placebo / Diluent

## Key facts

- **NCT ID:** NCT07176728
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-22
- **Primary completion:** 2026-06-02
- **Final completion:** 2026-06-02
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07176728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07176728, "A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07176728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*